Clinical Metagenomics for Infectious Diseases: Progress toward Operational Value
Journal of Clinical Microbiology · 2023
DOI: 10.1128/jcm.01267-22 ↗Kurz gefasst
Kommentar in der Zeitschrift Journal of Clinical Microbiology, 2023. Verfasst von David C Gaston. Beteiligte Einrichtung: Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee, USA. Hauptthemen laut MEDLINE: Metagenomics, Communicable Diseases. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
The field of clinical metagenomics for infectious disease diagnostics has advanced to combining questions of technical methodologies with best-use practices due to lowering barriers of implementation. This commentary identifies challenges facing further development of the field and proposes methods for advancement by highlighting a recent prospective pilot study evaluating a targeted metagenomic approach for infectious endocarditis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
ORCID-Profile: David C Gaston
Zitieren
APA
Gaston, D. C. (2023). Clinical Metagenomics for Infectious Diseases: Progress toward Operational Value. Journal of Clinical Microbiology. https://doi.org/10.1128/jcm.01267-22
Vancouver
Gaston DC. Clinical Metagenomics for Infectious Diseases: Progress toward Operational Value. Journal of Clinical Microbiology. 2023. doi:10.1128/jcm.01267-22
BibTeX
@article{Gaston2023,
author = {Gaston, David C},
title = {Clinical Metagenomics for Infectious Diseases: Progress toward Operational Value},
journal = {Journal of Clinical Microbiology},
year = {2023},
doi = {10.1128/jcm.01267-22}
}
EUVIMED